CDT · CDT Equity Inc. · Documents
Substantial doubt about the company's ability to continue as a going concern.
“Management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of at least 12 months from the date of the filing of this Quarterly Report. This is based on our analysis under applicable accounting principles. These unaudited condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern and do not include adjustments to reflect the possible effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Aug 12, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
CDT Equity Inc. will effect a 1-for-20 reverse stock split on November 5, 2026, at 5:00 p.m., Eastern Time, with split-adjusted trading expected on November 6, 2026, under ticker “CDT.”
CDT Equity Inc. seeks approval on November 12, 2026, at 10:00 a.m., Eastern Time, for J.J. Astor & Co. note and warrant share issuances and reverse stock splits ranging from 1-for-2 to 1-for-100, up to 1-for-1,000 in aggregate.
On October 22, 2026, CDT Equity Inc. agreed with Manoira Corporation to evaluate AZD1656 and AZD5904 in animal healthcare, settling a $195,000 fee with 1,347,616 common shares at $0.1447 each. Successful results could lead to licensing discussions.
CDT Equity Inc. will ask stockholders on November 12, 2026 to approve J.J. Astor & Co. note and warrant share issuances and authorize reverse stock splits ranging from 1-for-2 to 1-for-100, up to 1-for-1,000 aggregate.
CDT Equity Inc. issued J.J. Astor & Co. a $6,750,000 senior secured convertible note on October 6, 2026, funded $3,000,000 initially with a conditional $2,000,000 second tranche, plus warrants for 225,000 shares at $0.9177 per share.
CDT Equity Inc. approved a 1-for-25 reverse stock split to ensure continued Nasdaq bid-price compliance, effective September 28, 2026, with adjusted trading expected September 29, 2026 and outstanding shares reduced to approximately 1,124,515.